| Ytd | -21.86% | |
| 1y | 21.60% |
| Open | 61.31 | Prev Close | 61.55 | Low | 60.48 | High | 62.11 | Mkt Cap | 598.34M |
| Vol | 142.39K | Avg Vol | 190.94K | EPS | -2.04 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.13 | Short Ratio | 0.70 | Inst. Own | 44.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-17 | 50-d Avg | 73.74 | 200-d Avg | 77.91 | 1yr Est | 4.87 |
DRUG News
NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” o
Does Bright Minds Biosciences Inc. (DRUG) have what it takes to be a top stock pick for momentum inv
The average of price targets set by Wall Street analysts indicates a potential upside of 97% in Brig
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:D
BTIG analyst Thomas Shrader reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and main
The mean of analysts' price targets for Bright Minds Biosciences Inc. (DRUG) points to a 97.4% upsid
SOUTH SAN FRANCISCO, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Vistagen (Nasdaq: VTGN), a late clini
The consensus price target hints at a 107.5% upside potential for Bright Minds Biosciences Inc. (DRU
Bright Minds Biosciences Inc. (DRUG) might move higher on growing optimism about its earnings prospe
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:D
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or
Bright Minds Biosciences develops serotonin-based therapeutics for neurological and neuropsychiatric
Piper Sandler analyst Yasmeen Rahimi maintains Bright Minds Biosciences (NASDAQ:DRUG) with a Over
https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-ex
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
Jefferies analyst Andrew Tsai initiates coverage on Bright Minds Biosciences (NASDAQ:DRUG) with a
BTIG analyst Thomas Shrader reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and main
Bright Minds Biosciences Inc. (NASDAQ: DRUG - Get Free Report) has been given a consensus recommenda
https://www.marijuanamoment.net/bipartisan-senators-file-bill-to-support-psychedelics-research-and-t
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Bright Minds Biosciences (NASDAQ:DR
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or
BTIG analyst Thomas Shrader maintains Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and maint
Bright Minds Biosciences Inc. (NASDAQ: DRUG - Get Free Report) has been assigned an average rating o
NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG)
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG)
Bright Minds Biosciences remains a "Strong Buy" after positive phase 2 data for BMB-101 in drug-resi
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG)
Bright Minds Biosciences Inc. (NASDAQ: DRUG) stock is trading higher on Tuesday after the company sh
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (Nasdaq: DRUG)
Shares of Bright Minds Biosciences Inc (NASDAQ: DRUG, CSE:DRUG) jumped almost 25% after the company
– Conference Call and Live Webcast at 8AM ET – NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Bright Mi
https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-mari
https://www.marijuanamoment.net/rfk-says-trump-administration-could-provide-psychedelic-therapy-to-m
https://www.statnews.com/2025/06/18/fda-approval-psychedelics-rfk-jr-trump-allies-see-opening-mdma-p
https://www.marijuanamoment.net/alaska-activists-launch-campaign-to-put-psychedelics-legalization-me
Tuesday saw 132 companies set new 52-week lows.
On Thursday, 369 companies hit new 52-week lows.
Monday's session saw 175 companies set new 52-week lows.
Friday's session saw 225 companies set new 52-week lows.
On Thursday, 283 companies set new 52-week lows.
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesd
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company annou
On Tuesday, 91 stocks hit new 52-week lows.
On Monday, 198 companies hit new 52-week lows.
On Friday, 135 companies reached new 52-week lows.